IDEAYA Biosciences (IDYA) Invested Capital (2018 - 2026)

IDEAYA Biosciences has disclosed Invested Capital across 9 years of filings, most recently posting $937.3 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $937.3 million, down 8.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $937.3 million (down 8.48% YoY), and the FY2025 annual result was $1.0 billion, down 3.42% from the prior year.
• Invested Capital came in at $937.3 million for Q1 2026 at IDEAYA Biosciences, down from $1.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.2 billion in Q3 2024 to a low of $269.3 million in Q2 2022.
• The 5-year median for Invested Capital is $931.7 million (2024), against an average of $728.4 million.
• Across the five-year window, Invested Capital surged 180.19% in 2024 and declined 8.48% in 2026, its largest moves.
• IDEAYA Biosciences' Invested Capital stood at $349.5 million in 2022, then surged by 77.73% to $621.1 million in 2023, then surged by 70.53% to $1.1 billion in 2024, then retreated by 3.42% to $1.0 billion in 2025, then fell by 8.37% to $937.3 million in 2026.
• The last three Invested Capital figures came in at $937.3 million (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.